Aprogen Medicines Inc. (KRX:007460)

South Korea flag South Korea · Delayed Price · Currency is KRW
293.00
-24.00 (-7.57%)
Apr 15, 2026, 9:54 AM KST
-97.22%
Market Cap 90.40B
Revenue (ttm) 117.97B
Net Income (ttm) -70.20B
Shares Out 20.57M
EPS (ttm) -3,540.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,033,953
Average Volume 570,417
Open 317.00
Previous Close 317.00
Day's Range 293.00 - 326.00
52-Week Range 293.00 - 14,070.00
Beta 0.16
RSI 39.65
Earnings Date May 13, 2026

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam... [Read more]

Industry Conglomerates
Sector Industrials
Founded 2000
Employees 256
Stock Exchange Korea Stock Exchange
Ticker Symbol 007460
Full Company Profile

Financial Performance

In 2025, Aprogen Medicines's revenue was 117.97 billion, a decrease of -21.41% compared to the previous year's 150.11 billion. Losses were -70.20 billion, 20.9% more than in 2024.

Financial Statements

News

There is no news available yet.